循环VDAC3隔离microRNA-592并提高EIF4E3的表达,以抑制胃癌的进展
Tian-Ning Yang1, Ruo-Wen Xiao2, Fei Su1
1The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, PR China; Department of Oncology, The First Hospital of Lanzhou University, Lanzhou, Gansu, PR China.
Translational oncology
|May 5, 2024
概括
循环RNA VDAC3 (circVDAC3) 在胃癌 (GC) 中被下调,并抑制瘤生长和转移. 它通过circVDAC3/miR-592/EIF4E3通路运行,为GC提供潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 循环RNAs (circRNAs) 与胃癌 (GC) 的发展有关.
- 特定的功能性circRNA及其在GC中的机制需要进一步研究.
研究的目的:
- 确定和阐明一种新型circRNA在胃癌中的功能和机制.
主要方法:
- 使用微阵列数据对circRNAs的差异表达分析.
- 通过qRT-PCR和其他试验验证circVDAC3的表达和结构.
- 功能性研究包括基于细胞的测定和动物模型.
- 使用生物信息学,FISH和双 luciferase 试验的机制研究.
主要成果:
- 在GC组织中,circVDAC3表达的下调.
- circVDAC3抑制了GC细胞的增殖和转移.
- circVDAC3 作为 miR-592 的竞争性内源RNA (ceRNA),从而调节 EIF4E3 的表达.
- EIF4E3在GC下调,其被miR-592抑制与circVDAC3的抗癌作用有关.
结论:
- 通过circVDAC3/miR-592/EIF4E3轴,circVDAC3抑制了GC生长和转移.
- 这一途径为GC瘤发生提供了新的见解.
- circVDAC3代表了胃癌的潜在治疗标.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


